Skip to content
GLP-1 Savers
Menu
Ranked #168 · Watch List

Arc-1 review

Arc-1 sells compounded semaglutide and tirzepatide from $199.99 a month as per-dose purchases, inside a broader longevity storefront split by men's and women's programs.

By Grant Ashford, Founder & Pricing Editor

Est. first month

From $199/mo

Save ~85% vs brand-name

From $199.99/mo (compounded)

Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.
Pricing to watch. Arc-1 prices per dose rather than per plan, so the entry figure holds only at the entry dose - both molecules start at $199.99 and climb as you titrate. The row previously carried $249.99 and $299.99, which are rungs further up the same ladder, not the starting price.

How much does Arc-1 cost?

The price Arc-1 publishes is From $199.99/mo (compounded). We flag this one to watch: confirm the ongoing rate with Arc-1 before you count on it, because a low first month can step up afterward. That works out about 85% under our ~$1,349/mo brand-name cash reference.

Semaglutide
From $199.99/mo (compounded)
Tirzepatide
From $199.99/mo (compounded)
Coverage
Coverage not published
Brand-name
Compounded only

The Value Score card

Arc-1 scored on our six published factors. See the methodology.

Lowest Real Price72/100
No Teaser-Rate Bait72/100
Nationwide Availability45/100
Both Molecules92/100
Easy Cancellation95/100
Reputation63/100

Why it's a deal

  • Displays a LegitScript certification and states it works with US-licensed pharmacies and board-certified physicians
  • Both molecules open at the same figure, $199.99, so the choice between them is clinical rather than financial at the entry dose
  • HIPAA compliance is stated explicitly alongside the clinical claims
  • Prices are on the storefront rather than behind an intake

Read the fine print

  • Pricing is per dose, so the cost climbs every time you titrate up rather than holding flat
  • No legal entity name or business address is disclosed
  • The states it serves are not published, and no clinicians or pharmacy partners are named
  • GLP-1s sit inside a longevity catalog rather than being the specialism

The bottom line

Best for: Someone on a low dose who will re-price the program before each step up. Arc-1 sells compounded semaglutide and tirzepatide from $199.99 a month as per-dose purchases, inside a broader longevity storefront split by men's and women's programs.

Ranked #168 of 427 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Compare with other deals

The programs scoring closest to Arc-1, out of 426 others we track.

Shopping Arc-1 against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs Arc-1, and every program that undercuts or outscores it — starting with Science & Co, the closest match on score — is ranked on the Arc-1 alternatives ranking.

More programs we track (24)

396 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from Arc-1's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on Arc-1's site. Not medical advice; see our disclosure.

See every program ranked by price →

← Back to all deals